(Q53187961)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26832731%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Copy number gain of PIK3CA and MET is associated with poor prognosis in head and neck squamous cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26832731%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26832731%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Ede Birtalan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26832731%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Diána Brauswetter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26832731%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Kornél Dános

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26832731%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Éva Fruzsina Félegyházi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26832731%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Nóra Meggyesházi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26832731%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Tibor Krenács

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26832731%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

László Tamás

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26832731%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

István Peták

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26832731%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

29 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26832731%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26832731%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

468

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26832731%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26832731%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

579-587

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26832731%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00428-016-1905-1

6 March 2020

exact match

0 references

cites work

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

The molecular biology of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

COSMIC: exploring the world's knowledge of somatic mutations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

The biological role of HGF-MET axis in tumor growth and development of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

MET signalling: principles and functions in development, organ regeneration and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Met, metastasis, motility and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Genetic activation of the MET pathway and prognosis of patients with high-risk, radically resected gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: activation of MET as one mechanism for drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Targeting MET Amplification as a New Oncogenic Driver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Differential biomarker expression in head and neck cancer correlates with anatomical localization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Human papillomavirus and Epstein Barr virus in head and neck carcinomas: suggestions for the new WHO classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Partial p16 staining in oropharyngeal squamous cell carcinoma: extent and pattern correlate with human papillomavirus RNA status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

MET genetic abnormalities unreliable for patient selection for therapeutic intervention in oropharyngeal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

EGFR status in oral squamous cell carcinoma: comparing immunohistochemistry, FISH and CISH detection in a case series study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Comprehensive genomic characterization of head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1905-1

Cetuximab: its unique place in head and neck cancer treatment

21 January 2018

1 reference

12 December 2020

PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients.

1 reference

12 December 2020

Role of phosphatidylinositol-3-kinase pathway in head and neck squamous cell carcinoma

1 reference

12 December 2020

Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma

1 reference

12 December 2020

Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas

1 reference

12 December 2020

10.1007/S00428-016-1905-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26832731%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference